ArticleCurrent oncology (Toronto, Ont.)2022

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report.

Linlin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.